Evidence map›Paper›PMID 32918098›Full record

ArticleArchives of microbiology2021

Gene expressing analysis indicates the role of Pyrogallol as a novel antibiofilm and antivirulence agent against Acinetobacter baumannii.

Gurusamy Abirami, Ravindran Durgadevi, Palanivel Velmurugan, Arumugam Veera Ravi

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Antivirulence drugs against Acinetobacter baumannii: where do they stand?World journal of microbiology & biotechnology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Mechanism of Tigecycline Resistance inInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Pyrogallol and Fluconazole Interact SynergisticallyAntimicrobial agents and chemotherapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gurusamy AbiramiDepartment of Biotechnology, Alagappa University, Science Campus, Karaikudi, Tamilnadu, 630003, India.
Ravindran DurgadeviDepartment of Biotechnology, Alagappa University, Science Campus, Karaikudi, Tamilnadu, 630003, India.
Palanivel VelmuruganDepartment of Biotechnology, Alagappa University, Science Campus, Karaikudi, Tamilnadu, 630003, India.
Arumugam Veera RaviDepartment of Biotechnology, Alagappa University, Science Campus, Karaikudi, Tamilnadu, 630003, India. aveeraravi@rediffmail.com.ORCID http://orcid.org/0000-0002-4768-8389
Alagappa University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acinetobacter baumannii has emerged worldwide as a leading cause of hospital-acquired infections. Although A. baumannii was initially regarded to as a low-grade pathogen, evidence has been accumulated suggesting that A. baumannii infections are associated with increased mortality in critically ill patients. Here, we describe the efficacy of pyrogallol, a polyphenolic organic compound found in the galls and barks of various trees, which shows anti-biofilm and anti-virulence potential against A. baumannii. Pyrogallol shows concentration-based biofilm inhibition, as evidenced through light and confocal laser scanning microscopic analysis. The other virulence factors are protease, swarming motility, and extracellular polymeric substances that are also inhibited by pyrogallol. Through real-time PCR, it was found that pyrogallol downregulates expression of the biofilm and virulence-related ompA, bap, csuA/B, katE, pgaA, and pgaC genes. Furthermore, pyrogallol moderately inhibited the mature biofilms of A. baumannii in a concentration-dependent manner (5, 10, and 20 µg/ml). The present study reports that the anti-biofilm and anti-virulence potential of pyrogallol disrupts the biofilm formation, adherence of cells, and cell-to-cell signaling mechanism of A. baumannii. Thus, pyrogallol is a promising therapeutic agent for A. baumannii-related infections.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBiofilmsCross InfectionGene Expression ProfilingGene Expression Regulation, BacterialHumansPyrogallolVirulence FactorsAnti-Bacterial AgentsPyrogallolVirulence FactorsAcinetobacter baumanniiAnti-biofilmAnti-virulencePyrogallol

Identifiers

PMID32918098
OpenAlexW3085108103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.